Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Weller

Showing results (161-170 of 938) with videos related to

Pageof 94
Sort By:
International Journal of Cancer|October 12, 2005
Immune stimulatory effects of CD70 override CD70-mediated immune cell apoptosis in rodent glioma models and confer long-lasting antiglioma immunity in vivoSteffen Aulwurm, Jörg Wischhusen, Manuel Friese, et al.
Swiss Medical Weekly|January 9, 2013
The costs of disorders of the brain in Switzerland: an update from the European Brain Council Study for 2010Andreas Maercker, Axel Perkonigg, Martin Preisig, et al.
Acta Neuropathologica|May 22, 2013
Refined brain tumor diagnostics and stratified therapies: the requirement for a multidisciplinary approachMarkus J Riemenschneider, David N Louis, Michael Weller, et al.
Journal of Neurology|May 17, 2005
Relapse of primary CNS lymphoma after more than 10 years in complete remissionUlrich Herrlinger, Holger Hebart, Lothar Kanz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2003
Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant gliomaMichael Weller, Bettina Müller, Rainer Koch, et al.
Acta Neuropathologica|August 9, 2003
PTEN methylation and expression in glioblastomasNathalie Baeza, Michael Weller, Yasuhiro Yonekawa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2010
Bevacizumab and recurrent malignant gliomas: a European perspectiveWolfgang Wick, Michael Weller, Martin van den Bent, et al.
Journal of Vascular Surgery|June 13, 2006
Stenting of vertebrobasilar arteries in symptomatic atherosclerotic disease and acute occlusion: case series and review of the literatureOlaf Eberhardt, Thomas Naegele, Sabine Raygrotzki, et al.
Neuro-Oncology|December 12, 2013
A disintegrin and metalloproteinases 10 and 17 modulate the immunogenicity of glioblastoma-initiating cellsFabian Wolpert, Isabel Tritschler, Alexander Steinle, et al.
International Journal of Molecular Sciences|October 23, 2021
Androgen Receptor Activation in Glioblastoma Can Be Achieved by Ligand-Independent Signaling through EGFR-A Potential Therapeutic TargetNomi Zalcman, Mijal Gutreiman, Tal Shahar, et al.
Pageof 94

Showing results (161-170 of 938) with videos related to

Sort By:
Pageof 94
International Journal of Cancer|October 12, 2005
Immune stimulatory effects of CD70 override CD70-mediated immune cell apoptosis in rodent glioma models and confer long-lasting antiglioma immunity in vivoSteffen Aulwurm, Jörg Wischhusen, Manuel Friese, et al.
Swiss Medical Weekly|January 9, 2013
The costs of disorders of the brain in Switzerland: an update from the European Brain Council Study for 2010Andreas Maercker, Axel Perkonigg, Martin Preisig, et al.
Acta Neuropathologica|May 22, 2013
Refined brain tumor diagnostics and stratified therapies: the requirement for a multidisciplinary approachMarkus J Riemenschneider, David N Louis, Michael Weller, et al.
Journal of Neurology|May 17, 2005
Relapse of primary CNS lymphoma after more than 10 years in complete remissionUlrich Herrlinger, Holger Hebart, Lothar Kanz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2003
Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant gliomaMichael Weller, Bettina Müller, Rainer Koch, et al.
Acta Neuropathologica|August 9, 2003
PTEN methylation and expression in glioblastomasNathalie Baeza, Michael Weller, Yasuhiro Yonekawa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2010
Bevacizumab and recurrent malignant gliomas: a European perspectiveWolfgang Wick, Michael Weller, Martin van den Bent, et al.
Journal of Vascular Surgery|June 13, 2006
Stenting of vertebrobasilar arteries in symptomatic atherosclerotic disease and acute occlusion: case series and review of the literatureOlaf Eberhardt, Thomas Naegele, Sabine Raygrotzki, et al.
Neuro-Oncology|December 12, 2013
A disintegrin and metalloproteinases 10 and 17 modulate the immunogenicity of glioblastoma-initiating cellsFabian Wolpert, Isabel Tritschler, Alexander Steinle, et al.
International Journal of Molecular Sciences|October 23, 2021
Androgen Receptor Activation in Glioblastoma Can Be Achieved by Ligand-Independent Signaling through EGFR-A Potential Therapeutic TargetNomi Zalcman, Mijal Gutreiman, Tal Shahar, et al.
Pageof 94